|
|
.
See Category: Factors influencing health status and contact with health services
See Header: Encntr screen for malignant neoplasm of genitourinary organs
ICD-10 (CM) Code and Descriptor
|
Z12.79 |
Encounter for screening for malignant neoplasm of other genitourinary organs
This code is considered unacceptable as a principal diagnosis.
|
Z1279 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 18.45%
|
11.33%
|
11.46%
|
21.25%
|
11.93%
|
7.73%
|
5.73%
|
4.00%
|
2.20%
|
1.47%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z12.79*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
87624
|
HPV HI-RISK TYP POOLED RSLT |
30
|
30
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
26
|
26
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
20
|
20
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
19
|
19
|
|
80053
|
COMPREHEN METABOLIC PANEL |
18
|
18
|
|
76830
|
TRANSVAGINAL US NON-OB |
18
|
18
|
|
76856
|
US EXAM PELVIC COMPLETE |
16
|
16
|
|
88112
|
CYTOPATH CELL ENHANCE TECH |
15
|
15
|
|
83735
|
ASSAY OF MAGNESIUM |
15
|
15
|
|
G0145
|
SCR C/V CYTO,THINLAYER,RESCR |
14
|
14
|
|
80061
|
LIPID PANEL |
13
|
13
|
|
G0101
|
CA SCREEN;PELVIC/BREAST EXAM |
13
|
13
|
|
G0123
|
SCREEN CERV/VAG THIN LAYER |
12
|
12
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
11
|
1,042
|
|
76770
|
US EXAM ABDO BACK WALL COMP |
11
|
11
|
|
84100
|
ASSAY OF PHOSPHORUS |
11
|
11
|
|
84550
|
ASSAY OF BLOOD/URIC ACID |
11
|
11
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
10
|
228
|
|
82248
|
BILIRUBIN DIRECT |
9
|
9
|
|
G0467
|
FQHC VISIT, ESTAB PT |
9
|
9
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z12.79 related to the following DRG Codes:
951
|
